These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19014659)

  • 41. Microbicidas Metodo de Prevencion en VIH/SIDA Controlado por Mujeres.
    Ruiz C; Torres V; Cianelli R; Ferrer L
    Hisp Health Care Int; 2009 Mar; 7(1):35-48. PubMed ID: 28111528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.
    Okwundu CI; Uthman OA; Okoromah CA
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007189. PubMed ID: 22786505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal transmission of HIV-1: first stop dendritic cells.
    Wilkinson J; Cunningham AL
    Curr Drug Targets; 2006 Dec; 7(12):1563-9. PubMed ID: 17168831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.
    Cohen MS; Gay C; Kashuba AD; Blower S; Paxton L
    Ann Intern Med; 2007 Apr; 146(8):591-601. PubMed ID: 17438318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NIAID international AIDS research. National Institute of Allergy and Infectious Diseases.
    Bowersox J
    NIAID AIDS Agenda; 1996 Mar; ():12-5. PubMed ID: 11363794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
    PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Langerhans cell and HIV.
    Kawamura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):70-5. PubMed ID: 21628848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.
    Brault MA; Spiegelman D; Hargreaves J; Nash D; Vermund SH
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S104-S112. PubMed ID: 31658196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The human immunodeficiency virus epidemic in India. Current magnitude and future projections.
    Bollinger RC; Tripathy SP; Quinn TC
    Medicine (Baltimore); 1995 Mar; 74(2):97-106. PubMed ID: 7891548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical Microbicides in HIV Prevention: State of the Promise.
    Baeten JM; Hendrix CW; Hillier SL
    Annu Rev Med; 2020 Jan; 71():361-377. PubMed ID: 31613684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engagement in HIV care and sexual transmission risk behavior among men who have sex with men using online social/sexual networking in Latin America.
    Magidson JF; Biello KB; Safren SA; Rosenberger JG; Novak DS; Mayer KH; Mimiaga MJ
    AIDS Care; 2015; 27(8):1055-62. PubMed ID: 25738655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations.
    Koff A; Goldberg C; Ogbuagu O
    Ann Med; 2017 Sep; 49(6):534-544. PubMed ID: 28409656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally.
    Burr CK; Lampe MA; Corle S; Margolin FS; Abresh C; Clark J;
    J Public Health Policy; 2007 Jul; 28(2):249-60. PubMed ID: 17585325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbicides: a woman-controlled HIV prevention method in the making.
    Lerner S
    SIECUS Rep; 1994; 22(5):10-3. PubMed ID: 12345598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.